Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium citrate and hydrochlorothiazide for prevention of ureteral stent encrustation
IRCT20180625040232N3Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of potassium citrate and hydrochlorothiazide in ureteral stent encrustation (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Stent encrustation and Duration of stent in situ. Started Feb 2020; status: completed.
02
Drugs
potassium citratehydrochlorothiazide
03
Conditions
ureteral stent encrustation
Beyond the preview
Go deeper on IRCT20180625040232N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180625040232N3.